⌘K

Login Start Free

Home/Filings/4/0001171843-18-003058

4//SEC Filing

Katz Richard D 4

Accession 0001171843-18-003058

CIK 0001105533other

View on SEC.gov Company Profile

Filed

Apr 24, 8:00 PM ET

Accepted

Apr 25, 4:58 PM ET

Size

4.7 KB

Accession

0001171843-18-003058

Insider Transaction Report

Form 4

Period: 2018-04-25

ARGOS THERAPEUTICS INCARGS

VP & Chief Financial Officer

Transactions

Disposition to Issuer
Common Stock
2018-04-25−22,629→ 9,697 total

Footnotes (1)

[F1]Represents shares forfeited upon the delisting of the Company's common stock from The Nasdaq Capital Market.

Documents

1 file

4
formfour.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

ARGOS THERAPEUTICS INC

CIK 0001105533

Entity typeother

Related Parties

1

filerCIK 0001293577

Filing Metadata

Form type: 4
Filed: Apr 24, 8:00 PM ET
Accepted: Apr 25, 4:58 PM ET
Size: 4.7 KB

View on SEC.gov